290 results on '"Zimmer, Gert"'
Search Results
2. Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screen.
3. Optimized intramuscular immunization with VSV-vectored spike protein triggers a superior immune response to SARS-CoV-2
4. Evaluation of a novel intramuscular prime/intranasal boost vaccination strategy against influenza in the pig model.
5. Rhabdoviruses as Vaccine Vectors for Veterinary Pathogens
6. Aging shapes infection profiles of influenza A virus and SARS-CoV-2 in human lung slices
7. Intramuscular prime/intranasal boost vaccination to induce sterilizing immunity against influenza A virus infection
8. Neutrophil proteases are protective against SARS-CoV-2 by degrading the spike protein and dampening virus-mediated inflammation
9. MicroRNAs modulate SARS‐CoV‐2 infection of primary human hepatocytes by regulating the entry factors ACE2 and TMPRSS2.
10. LY6E impairs coronavirus fusion and confers immune control of viral disease
11. Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants
12. Rhabdoviruses as Vaccine Vectors for Veterinary Pathogens
13. The M2 proteins of bat influenza A viruses reveal atypical features compared to conventional M2 proteins
14. Bat Influenza A-like Viruses
15. MHC class II proteins mediate cross-species entry of bat influenza viruses
16. NS1 and PA-X of H1N1/09 influenza virus act in a concerted manner to manipulate the innate immune response of porcine respiratory epithelial cells
17. Synthetically derived bat influenza A-like viruses reveal a cell type- but not species-specific tropism
18. Supporting data for Macrophage phagocytosis of SARS-CoV-2-infected cells mediates potent plasmacytoid dendritic cell activation
19. Sex‐specific differences in immune response to SARS‐CoV‐2 vaccination vanish with age
20. Relevance of microRNAs in SARS-CoV-2 infection of primary human hepatocytes
21. In-depth analysis of T cell immunity and antibody responses in heterologous prime-boost-boost vaccine regimens against SARS-CoV-2 and Omicron variant
22. Non-neutralizing antibody responses to vesicular stomatitis virus-vectored influenza A virus vaccines correlate with protection
23. Sex-specific differences in immune response to SARS-CoV-2 vaccination vanish with age
24. Species-Specific Molecular Barriers to SARS-CoV-2 Replication in Bat Cells
25. Optimized intramuscular immunization with VSV-vectored spike protein triggers a superior protective humoral immune response to SARS-CoV-2
26. Potent neutralization by monoclonal human IgM against SARS‐CoV‐2 is impaired by class switch
27. Stability and inactivation of vesicular stomatitis virus, a prototype rhabdovirus
28. Influenzavirus C : Orthomyxoviridae
29. Are Intestinal Mucins Involved in the Pathogenicity of Transmissible Gastroenteritis Coronavirus?
30. Biparatopic sybodies neutralize SARS‐CoV‐2 variants of concern and mitigate drug resistance
31. Improved cellular and humoral immunity upon a second BNT162b2 and mRNA-1273 boost in prime-boost vaccination no/low responders with end-stage renal disease
32. A genome-wide CRISPR screen identifies interactors of the autophagy pathway as conserved coronavirus targets
33. Sweet Drugs for Bad Bugs: A Glycomimetic Strategy against the DC-SIGN-Mediated Dissemination of SARS-CoV-2
34. Ninety-day outcome of patients with severe COVID-19 treated with tocilizumab – a single centre cohort study
35. A recombinant vesicular stomatitis virus replicon vaccine protects chickens from highly pathogenic avian influenza virus (H7N1)
36. Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient: a source of immune escape variants
37. Sweet Drugs for Bad Bugs: A Glycomimetic Strategy against the DC-SIGN-Mediated Dissemination of SARS-CoV-2
38. No Evidence for Human Monocyte-Derived Macrophage Infection and Antibody-Mediated Enhancement of SARS-CoV-2 Infection
39. A novel circulating tamiami mammarenavirus shows potential for zoonotic spillover
40. A novel circulating tamiami mammarenavirus shows potential for zoonotic spillover
41. A genetically engineered prime-boost vaccination strategy for oculonasal delivery with poly( d,l-lactic- co-glycolic acid) microparticles against infection of turkeys with avian Metapneumovirus
42. A novel circulating tamiami mammarenavirus shows potential for zoonotic spillover
43. Biparatopic sybody constructs neutralize SARS-CoV-2 variants of concern and mitigate emergence of drug resistance
44. An infectious bat-derived chimeric influenza virus harbouring the entry machinery of an influenza A virus
45. Rapid Quantification of SARS-CoV-2-Neutralizing Antibodies Using Propagation-Defective Vesicular Stomatitis Virus Pseudotypes
46. LY6E impairs coronavirus fusion and confers immune control of viral disease
47. T-cell immunoglobulin and mucin (TIM) contributes to Hantaan virus entry into human airway epithelial cells
48. Macropinocytosis contributes to hantavirus entry into human airway epithelial cells
49. Phosphorylation of TRIM28 Enhances the Expression of IFN-β and Proinflammatory Cytokines During HPAIV Infection of Human Lung Epithelial Cells
50. Macropinocytosis contributes to hantavirus entry into human airway epithelial cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.